State of the Art in Tumor Antigen and Biomarker Discovery
AbstractOur knowledge of tumor immunology has resulted in multiple approaches for the treatment of cancer. However, a gap between research of new tumors markers and development of immunotherapy has been established and very few markers exist that can be used for treatment. The challenge is now to discover new targets for active and passive immunotherapy. This review aims at describing recent advances in biomarkers and tumor antigen discovery in terms of antigen nature and localization, and is highlighting the most recent approaches used for their discovery including “omics” technology. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Even-Desrumeaux, K.; Baty, D.; Chames, P. State of the Art in Tumor Antigen and Biomarker Discovery. Cancers 2011, 3, 2554-2596.
Even-Desrumeaux K, Baty D, Chames P. State of the Art in Tumor Antigen and Biomarker Discovery. Cancers. 2011; 3(2):2554-2596.Chicago/Turabian Style
Even-Desrumeaux, Klervi; Baty, Daniel; Chames, Patrick. 2011. "State of the Art in Tumor Antigen and Biomarker Discovery." Cancers 3, no. 2: 2554-2596.